Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kreikemeyer

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|July 17, 2001
Persistence of group A streptococci in eukaryotic cells--a safe place?A Podbielski, B Kreikemeyer
FEMS Microbiology Letters|November 11, 1999
An Escherichia coli-Enterococcus faecalis shuttle vector as a tool for the construction of a group B Streptococcus heterologous mutant expressing the beta antigen (Bac) of the C protein complexB Kreikemeyer, P G Jerlström
Infection and Immunity|December 19, 2000
Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalizationS Beckert, B Kreikemeyer, A Podbielski
Gut|November 21, 2007
Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse modelC Maletzki, M Linnebacher, B Kreikemeyer, et al.
FEMS Microbiology Letters|September 28, 1999
SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activityB Kreikemeyer, D R Martin, G S Chhatwal
Molecular Microbiology|July 1, 1995
Characterization of a novel fibronectin-binding surface protein in group A streptococciB Kreikemeyer, S R Talay, G S Chhatwal
Clinical & Developmental Immunology|November 30, 2012
Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's ToxinC Maletzki, U Klier, W Obst, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 3, 1999
Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cellsD Joh, E R Wann, B Kreikemeyer, et al.
Medical Microbiology and Immunology|February 7, 2001
Cysteine protease SpeB expression in group A streptococci is influenced by the nutritional environment but SpeB does not contribute to obtaining essential nutrientsA Podbielski, M Woischnik, B Kreikemeyer, et al.
The Journal of Hospital Infection|May 6, 2019
Molecular epidemiology study of a nosocomial Moraxella catarrhalis outbreak in a neurological rehabilitation unitP Warnke, T Köller, B Kreikemeyer, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|July 17, 2001
Persistence of group A streptococci in eukaryotic cells--a safe place?A Podbielski, B Kreikemeyer
FEMS Microbiology Letters|November 11, 1999
An Escherichia coli-Enterococcus faecalis shuttle vector as a tool for the construction of a group B Streptococcus heterologous mutant expressing the beta antigen (Bac) of the C protein complexB Kreikemeyer, P G Jerlström
Infection and Immunity|December 19, 2000
Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalizationS Beckert, B Kreikemeyer, A Podbielski
Gut|November 21, 2007
Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse modelC Maletzki, M Linnebacher, B Kreikemeyer, et al.
FEMS Microbiology Letters|September 28, 1999
SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activityB Kreikemeyer, D R Martin, G S Chhatwal
Molecular Microbiology|July 1, 1995
Characterization of a novel fibronectin-binding surface protein in group A streptococciB Kreikemeyer, S R Talay, G S Chhatwal
Clinical & Developmental Immunology|November 30, 2012
Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's ToxinC Maletzki, U Klier, W Obst, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|August 3, 1999
Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cellsD Joh, E R Wann, B Kreikemeyer, et al.
Medical Microbiology and Immunology|February 7, 2001
Cysteine protease SpeB expression in group A streptococci is influenced by the nutritional environment but SpeB does not contribute to obtaining essential nutrientsA Podbielski, M Woischnik, B Kreikemeyer, et al.
The Journal of Hospital Infection|May 6, 2019
Molecular epidemiology study of a nosocomial Moraxella catarrhalis outbreak in a neurological rehabilitation unitP Warnke, T Köller, B Kreikemeyer, et al.
Pageof 2